Register
Journal Updates
eMediNexus Coverage from: 
FDA Approves Midazolam Nasal Spray for Seizure Clusters
eMediNexus,  21 May 2019
remove_red_eye 515 Views
#Neurology #Pharmacist #Public Health

1 Read Comments                

The US Food and Drug Administration (FDA) has approved midazolam nasal spray for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in epilepsy patients aged 12 or above.Midazolam nasal spray is the first and only FDA-approved nasal option for treating seizure clusters. It is packaged as a single-use treatment that can be carried wi
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!